Orforglipron vs Semax
Overview
Orforglipron is primarily a weight management & metabolic peptide, while Semax is used for cognitive enhancement.
This page compares Orforglipron and Semax across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Orforglipron | Semax | |
|---|---|---|
| Category | Weight Management & Metabolic | Cognitive Enhancement |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | Clinical trials | 300-600 mcg |
| Frequency | daily | daily |
| Reported benefits | Oral administration convenience, weight loss, glucose control | Enhanced focus and memory, neuroprotection, improved learning, mood enhancement, stress resilience |
| Reported side effects | Under investigation | Generally safe. Possible: overstimulation, sleep disturbances if taken late |
Key differences
Primary use. Orforglipron is categorised under Weight Management & Metabolic, while Semax falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Orforglipron: FDA-approved. Semax: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Orforglipron is typically dosed at Clinical trials (daily). Semax is typically dosed at 300-600 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Orforglipron and Semax has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Orforglipron and Semax?
- Orforglipron is primarily a weight management & metabolic peptide, while Semax is used for cognitive enhancement. Orforglipron is FDA-approved for one or more indications, whereas Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Orforglipron used for?
- Oral GLP-1.
- What is Semax used for?
- Cognitive enhancement, focus, memory.
- Can you take Orforglipron and Semax together?
- Some users combine peptides within a single protocol, but stacking Orforglipron and Semax has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Orforglipron or Semax FDA-approved?
- Orforglipron is FDA-approved for one or more indications. Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Orforglipron — full monograph: mechanism, research, dosing & references
- Semax — full monograph: mechanism, research, dosing & references